Various financial firms, including JPMorgan Chase & Co. and Barclays, made rating upgrades, rating reaffirms, and acquired new stakes in a company during the second quarter of 2026.
4 reports, 2 independent
Updated Oct 24
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Various financial firms, including JPMorgan Chase & Co. and Barclays, made rating upgrades, rating reaffirms, and acquired new stakes in a company during the second quarter of 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
SpaceX
American private aerospace company
-
Cantor Fitzgerald
American financial services company
-
Orion Capital Management
Czech company
Nothing else this week.
Related events
- Multiple financial firms acquired new stakes in SpaceX shares and reaffirmed buy ratings on October 13, 2026.
- Avalo Therapeutics received multiple rating changes and analyst coverage from firms including Cantor Fitzgerald, Bank of America, and Weiss Ratings.
- Cantor Fitzgerald and Citigroup restated positive rating upgrades for Sagimet Biosciences.
- Agilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.
- Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in SpaceX stock by 16.8%.